Clinical Trial Update: Autologous Angiogenic Cell Precursors (ACPs) for the Treatment of Peripheral Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of autologous angiogenic cell precursors for peripheral artery disease, including critical limb ischemia, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• Autologous Angiogenic Cell Precursors (ACPs) (autologous angiogenic cell precursor)

Snippet

Sponsor: Salus Ltd. | Conditions: Critical Limb Ischemia | Phase 2 | Status: COMPLETED